NEFH-tTA transgenic line 8 has the human neurofilament heavy polypeptide promoter directing tetracycline-controlled transactivator protein (tTA) expression primarily to large-caliber axons of the brain and spinal cord. These mice are a "Tet-Off" tool useful for studying neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), as well as other neurobiological, neurodevelopmental, neuromuscular and aging studies involving the neurons of the brain and spinal cord.
Virginia M Lee, University of Pennsylvania
Genetic Background | Generation |
---|---|
N18+pN1F10
|
Allele Type |
---|
Transgenic (Transactivator) |
Starting at:
$255.00 Domestic price for female 4-week |
333.51 Domestic price for breeder pair |
NEFH-tTA transgenic mice have the human neurofilament heavy polypeptide (NEFH) promoter directing expression of tetracycline-controlled transactivator protein (tTA) to neurons with large-caliber axons of the brain and spinal cord. NEFH-tTA transgenic line 8 has its highest tTA expression in developmental late stage of the cortex, cerebellum and hippocampus, with expression also observed in olfactory bulb and in the rest of the brain. When mated to a second strain carrying a gene of interest under the regulatory control of a tetracycline-responsive promoter element (TRE; tetO), expression of the target gene can be blocked by administration of the tetracycline analog, doxycycline (dox).
For example, NEFH-tTA mice are useful in studying brain disorders such as amyotrophic lateral sclerosis (ALS) / frontotemporal lobar degeneration (FTLD) when used in conjunction with tetO-hTDP-43 transgenic mice. Specifically, the regulatable NLS (rNLS8) double transgenic line is created by breeding NEFH-tTA line 8 with TRE-promoter-driven cytoplasmic-insoluble human TDP-43ΔNLS transgenic mice (tetO-hTDP-43-ΔNLS line 4 ; Stock No. 014650). On a mixed C57BL/6J x C3HeJ F1 genetic background, rNLS8 mice exhibit widespread, high levels of hTDP-43ΔNLS expression in neurons of both the brain and spinal cord (SC) as early as 1 week off-dox. The brain/SC combination of hTDP-43-ΔNLS expression accounts for the spinal motor neuron loss and muscle denervation; resulting in a rapid, robust and progressive neurodegenerative ALS-like phenotype (including motor deficits, denervation of neuromuscular junctions, motor neuron loss and premature death at ~8-20 weeks). Upon administration of dox, the observed TDP-43 pathology and functional deficits were found to be largely reversible, even after neurodegeneration was underway (~8 weeks of hTDP-43-ΔNLS expression). Breeding NEFH-tTA with TRE-promoter-driven human TDP-43 wildtype transgenic mice (tetO-hTDP-43-WT line 12 ; Stock No. 016841) provides a regulatable control double transgenic line that exhibits broad nuclear hTDP-43-WT expression in the brain and spinal cord, without the formation of cytoplasmic TDP-43 pathology.
In addition, breeding NEFH-tTA mice to tetO-hα-syn-A53T line 33 (Stock No. 016976) allows studying Parkinson's disease.
Importantly, the donating investigator reports that this human NEFH promoter drives slightly higher levels of tTA expression in the cortex compared to their experiences with the mouse Camk2a promoter used in Camk2a-tTA mice (greater than ~10-fold higher than endogenous NEFH versus ~8-fold higher than endogenous CAMK2A). In addition, the human NEFH promoter directs tTA expression in spinal cord (whereas the mouse Camk2a promoter did not).
Hemizygous NEFH-tTA mice are viable and fertile, have normal lifespan out to latest date tested (18 months) and have no observed abnormalities. Homozygous mice are viable. The donating investigator reports that breeding homozyotes to wildtype animals results in hemizygous offspring, but breeding homozygous mice together did not generate any offspring.
NEFH-tTA transgenic mice were designed in the laboratory of Dr. Virginia Man-Yee Lee (University of Pennsylvania) to have ~18 kbp of the human neurofilament heavy polypeptide promoter (NEFH; from BAC RP11-91J21) upstream of the tetracycline-regulated transactivator gene (tTA or "Tet-Off"), all followed by a polyA signal. The NEFH-tTA transgene was injected into the pronucleus of fertilized eggs from (C57BL/6J x C3HeJ)F1 matings (Stock No. 100010). Founder animals were bred to B6C3F1/Crl for germline transmission, and founder line 8 was established. NEFH-tTA transgenic line 8 was then maintained by breeding hemizygous males with B6C3F1/Crl females for at least three generations prior to sending to The Jackson Laboratory Repository in 2013. Upon arrival, sperm was cryopreserved. To establish our living colony, an aliquot of the frozen sperm was used to fertilize oocytes from B6C3F1/J females (Stock No. 100010).
The donating investigator reports that the transgene insertion site(s) and copy number are not known. Multiple copies are likely, however, as the expression level is 9-10-fold greater than endogenous levels.
Expressed Gene | tTA, tetracycline-controlled transactivator, E. coli |
---|---|
Site of Expression | tTA is expressed in developmental late stage of the cortex, cerebellum and hippocampus, with expression also observed in olfactory bulb and in the rest of the brain. |
Allele Name | transgene insertion 8, Virginia M-Y Lee |
---|---|
Allele Type | Transgenic (Transactivator) |
Allele Synonym(s) | NEFH-tTA |
Gene Symbol and Name | Tg(NEFH-tTA)8Vle, transgene insertion 8, Virginia M-Y Lee |
Gene Synonym(s) | |
Promoter | NEFH, neurofilament heavy, human |
Expressed Gene | tTA, tetracycline-controlled transactivator, E. coli |
Site of Expression | tTA is expressed in developmental late stage of the cortex, cerebellum and hippocampus, with expression also observed in olfactory bulb and in the rest of the brain. |
Strain of Origin | (C57BL/6J x C3H/HeJ)F1 |
Chromosome | UN |
Molecular Note | The construct consists of ~18 kbp of the human neurofilament heavy polypeptide promoter (NEFH; from BAC RP11-91J21) upstream of the tetracycline-regulated transactivator gene (tTA or "Tet-Off"), followed by a polyA signal. Founder line 8 has its highest tTA expression in developmental late stage of the cortex, cerebellum and hippocampus, with expression also observed in olfactory bulb and in the rest of the brain. |
When maintained as a live colony, hemizygous mice may be bred to wildtype (non-carrier) mice from the colony or to B6C3F1/J mice (Stock No. 100010).
Hemizygous NEFH-tTA mice are viable and fertile, have normal lifespan out to latest date tested (18 months) and have no observed abnormalities. Homozygous mice are viable. The donating investigator reports that breeding homozyotes to wildtype animals results in hemizygous offspring, but breeding homozygous mice together did not generate any offspring.
When using the NEFH-tTA line 8 mouse strain in a publication, please cite the originating article(s) and include JAX stock #025397 in your Materials and Methods section.
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non carrier for Tg(NEFH-tTA)8Vle |
Frozen Mouse Embryo | B6;C3-Tg(NEFH-tTA)8Vle/J | $2595.00 |
Frozen Mouse Embryo | B6;C3-Tg(NEFH-tTA)8Vle/J | $2595.00 |
Frozen Mouse Embryo | B6;C3-Tg(NEFH-tTA)8Vle/J | $3373.50 |
Frozen Mouse Embryo | B6;C3-Tg(NEFH-tTA)8Vle/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.